OppenheimerFunds’s Ingevity NGVT Stock Holding History

OppenheimerFunds’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$71.1M	Sell	673,281 -130,233	-16%	-$13.1M	0.09%	231
2018 Q4	$67.2M	Buy	803,514 +92,909	+13%	+$8.41M	0.1%	214
2018 Q3	$72.4M	Buy	710,605 +241,336	+51%	+$23.3M	0.08%	254
2018 Q2	$37.9M	Buy	469,269 +51,632	+12%	+$4.1M	0.05%	397
2018 Q1	$30.8M	Buy	417,637 +31,642	+8%	+$2.37M	0.04%	439
2017 Q4	$27.2M	Buy	385,995 +11,951	+3%	+$862K	0.03%	488
2017 Q3	$23.4M	Buy	374,044 +42,697	+13%	+$2.53M	0.03%	517
2017 Q2	$19M	Sell	331,347 -203,354	-38%	-$12M	0.02%	571
2017 Q1	$32.5M	Buy	534,701 +34,656	+7%	+$1.96M	0.04%	421
2016 Q4	$27.4M	Buy	500,045 +143,138	+40%	+$6.86M	0.03%	473
2016 Q3	$16.5M	Buy	356,907 +303,073	+563%	+$12.8M	0.02%	628
2016 Q2	$1.83M	Buy	+53,834	New	+$1.68M	﹤0.01%	888

Other funds holding NGVT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

OppenheimerFunds's NGVT Position: Q1 2019 in Review

OppenheimerFunds reduced its Ingevity (NGVT) stake by 16% in Q1 2019, selling an estimated $13.1M and leaving 673,281 shares worth $71.1M. The position accounts for 0.09% of the portfolio, ranked #231.

OppenheimerFunds first reported a position in NGVT in Q2 2016 and has held it in 12 quarters since. The position peaked at $72.4M in Q3 2018. 361 funds tracked by Wall St. Rank hold NGVT as of Q1 2019.

OppenheimerFunds held 673,281 shares of Ingevity worth $71.1M as of Q1 2019.
OppenheimerFunds sold 130,233 Ingevity shares in Q1 2019, an estimated $13.1M.
Ingevity made up 0.09% of OppenheimerFunds's portfolio in Q1 2019, its #231 holding.
OppenheimerFunds first reported a position in Ingevity in Q2 2016 and has held it in 12 quarters since.
OppenheimerFunds's Ingevity position peaked at $72.4M in Q3 2018.
361 funds tracked by Wall St. Rank held Ingevity as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.